Cross platform analysis of drug targets and toxicity of bath salts

NIH RePORTER · NIH · U01 · $389,265 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY/ABSTRACT The parent award is focused on studying the mechanisms of novel psychoactive agents, with an emphasis on phenethylamines. Some of these agents are hallucinogenic and induce pronounced long term changes in dendritic branching and synaptic plasticity (termed as psychoplastogens). Even acute treatments with dimethyltryptamine (DMT), an agent from a related class (an indole-alkylamine) results in long term synaptic rewiring. The mechanisms behind these effects are the focus of significant interest for neuropsychiatric disorders and may have applications for dementia and Alzheimer’s disease (AD). Recent evidence indicates they may work via direct activation of TrkB, but most investigations have focused on traditional targets associated with these agents, such as 5-HT1A/2A, and few studies have used AD models. We propose to study binding partners of psychoplastogens and effects of kinase signaling and gene expression in human AD patients derived iPSCs via multi-omic analysis.

Key facts

NIH application ID
10939799
Project number
3U01DA054330-03S1
Recipient
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
Principal Investigator
Isaac T Schiefer
Activity code
U01
Funding institute
NIH
Fiscal year
2024
Award amount
$389,265
Award type
3
Project period
2022-09-15 → 2027-06-30